The term "lymphoma" describes a heterogeneous group of cancers with different biology and prognoses. In general, lymphomas are divided into two large groups of neoplasms: non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma. About 85% of all malignant lymphomas are NHLs. The median age at diagnosis is the sixth decade of life, although Burkitt lymphoma and lymphoblastic lymphoma occur in younger patients.
NHL includes many clinicopathologic subtypes, each with distinct epidemiologies; etiologies; morphologic, immunophenotypic, genetic, and clinical features; and responses to therapy. With respect to prognosis, NHLs can be divided into two groups: indolent and aggressive. Various laboratory and imaging studies are used in the evaluation and staging of suspected NHL, and the treatment widely varies, depending on tumor stage, grade, and type and various patient factors (eg, symptoms, age, performance status).
Are you familiar with key aspects of the epidemiology and etiology, diagnosis, and treatment of NHL? Test your knowledge with this short quiz.
Medscape © 2018 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Emmanuel C. Besa. Fast Five Quiz: Test Your Knowledge on Key Aspects of Non-Hodgkin Lymphoma - Medscape - Aug 20, 2018.